ENFERMEDADES RESPIRATORIAS
Hospital Universitario La Fe
Valencia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Fe (34)
2024
-
Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry
Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152
-
Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia
Scientific reports, Vol. 14, Núm. 1, pp. 12726
-
Cost-Sensitive Ordinal Classification Methods to Predict SARS-CoV-2 Pneumonia Severity
IEEE Journal of Biomedical and Health Informatics, Vol. 28, Núm. 5, pp. 2613-2623
-
Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial
Chest, Vol. 165, Núm. 3, pp. 673-681
2023
-
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Viruses, Vol. 15, Núm. 7
-
Extracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques
PLoS ONE, Vol. 18, Núm. 4 April
-
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study
Thrombosis Research, Vol. 228, pp. 1-9
-
Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia
Science of the Total Environment, Vol. 894
-
Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
Frontiers in Medicine, Vol. 10
-
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19
International Journal of COPD, Vol. 18, pp. 2473-2481
-
Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
Microorganisms, Vol. 11, Núm. 11
-
Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors
Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82
-
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism
American Heart Journal, Vol. 257, pp. 62-68
2022
-
Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities
International Journal of Infectious Diseases, Vol. 115, pp. 39-47
-
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences
Infection, Vol. 50, Núm. 1, pp. 179-189
-
Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis
Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 281-283
-
Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
Chest, Vol. 162, Núm. 4, pp. 768-781
-
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism
Chest, Vol. 161, Núm. 2, pp. 524-534
2021
-
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial
JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285
-
The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 6, pp. 1075-1085